Related Experiment Video
Updated: Jun 27, 2025

07:44
A Porcine Model of Acute Autologous Pulmonary Embolism
Published on: September 6, 2024
343
Pulmonary Embolism: An Update Based on the Revised AWMF-S2k Guideline.
Christian F Opitz1, F Joachim Meyer2
1DRK Kliniken Berlin Westend, Spandauer Damm 130, Berlin, Germany.
Hamostaseologie
|April 30, 2024
Summary
Pulmonary embolism (PE) is a common, high-mortality cardiovascular disease. Diagnosis involves risk stratification and imaging like CTPA, with treatments ranging from anticoagulation to intensive care interventions.
Area of Science:
- Cardiovascular Medicine
- Pulmonary Medicine
- Diagnostic Imaging
Background:
- Pulmonary embolism (PE) is a leading cause of acute cardiovascular disease with significant mortality.
- Increasing age is a primary risk factor for PE.
- Clinical presentation of PE is often nonspecific, necessitating careful diagnostic evaluation.
Purpose of the Study:
- To outline the diagnostic and therapeutic strategies for pulmonary embolism.
- To emphasize the importance of patient stratification in managing PE.
- To provide an overview of the current treatment spectrum for PE.
Main Methods:
- Clinical likelihood assessment to guide diagnostic pathways.
- D-dimer testing in hemodynamically stable patients with low/intermediate PE probability.
- Computed tomography pulmonary angiography (CTPA) and ultrasound for thromboembolism visualization.
Main Results:
- Patient stratification into hemodynamically stable and unstable groups impacts diagnostic and therapeutic decisions.
- Risk stratification after PE confirmation guides treatment intensity and setting.
- A broad therapeutic spectrum exists, from outpatient anticoagulation to intensive care interventions.
Conclusions:
- Effective management of PE relies on accurate risk stratification and appropriate diagnostic modalities.
- Treatment approaches for PE are tailored to disease severity and patient stability.
- The management of PE encompasses a range of interventions, from conservative to aggressive therapies.
Related Concept Videos
Pleural Effusion II: Symptoms and Management
165
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
165
Pneumonia IV: Management
323
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
323
Pneumonia III: Complications and Assessment
204
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
204
Flail Chest-II
167
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Assessment:
1. Clinical Evaluation:
History:
167
Pneumothorax-II
141
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
141
Pneumonia V: Nursing management and Prevention
2.0K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.0K

